334648 <common-name>2-[[3-[[(z)-1-(2-chloroanilino)-3-hydroxy-1-oxobut-2-en-2-yl]diazenyl]-4-hydroxyphenyl]sulfonylamino]benzoic acid</common-name> <description>2-[[3-[[(z)-1-(2-chloroanilino)-3-hydroxy-1-oxobut-2-en-2-yl]diazenyl]-4-hydroxyphenyl]sulfonylamino]benzoic acid has the chemical formula C23H19ClN4O7S. With an average molecular weight of 530.90 g/mol, 2-[[3-[[(z)-1-(2-chloroanilino)-3-hydroxy-1-oxobut-2-en-2-yl]diazenyl]-4-hydroxyphenyl]sulfonylamino]benzoic acid is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>135850401</pubchem-id> <chemical-formula>C23H19ClN4O7S</chemical-formula> <weight>530.9</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T16:25:30Z</created-at> <updated-at type="dateTime">2026-08-30T16:25:30Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(=C(C(=O)NC1=CC=CC=C1Cl)N=NC2=C(C=CC(=C2)S(=O)(=O)NC3=CC=CC=C3C(=O)O)O)O</moldb-smiles> <moldb-formula>C23H19ClN4O7S</moldb-formula> <moldb-inchi>InChI=1S/C23H19ClN4O7S/c1-13(29)21(22(31)25-18-9-5-3-7-16(18)24)27-26-19-12-14(10-11-20(19)30)36(34,35)28-17-8-4-2-6-15(17)23(32)33/h2-12,28-30H,1H3,(H,25,31)(H,32,33)/b21-13-,27-26?</moldb-inchi> <moldb-inchikey>WPUVWVMHSPKJHI-SYJNUNNXSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">530.0662978</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.8</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM330541</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[3-[[(z)-1-(2-chloroanilino)-3-hydroxy-1-oxobut-2-en-2-yl]diazenyl]-4-hydroxyphenyl]sulfonylamino]benzoic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom nil="true"/> <superklass nil="true"/> <klass nil="true"/> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0285125</sync-id> <structure-inchikey>WPUVWVMHSPKJHI-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>8002000000000000080080000000000000000000000000002000000000000000000800000000001000000024002000004000000000000000084000000000200004000000000400000000000000000000020000000000000001004000040200000000000010000000200000100100000000000001000000000020000000400400000010040000000800000000000000080000000000100200080000000008200000000000000000000000000080000000000000001000000180000000000000800000000000200002100000000000000000010008000000000000200000000020000008000000000000040000000200400000000000000040100000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJgAAAIABBgBgAAAAAQMGACgAAAAD BAYAKAAAAAMEBgAoAAAAAwQIACgAAAADAgcAaAAAAAMCAQZAKAAAAAMEBkBo AAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQRACAA AAABBwAoAAAAAwMHACgAAAADAwZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEG QGgAAAADAwEGQCgAAAADBAZAaAAAAAMDARAAIAAAAAYIACgAAAADAggAKAAA AAMCBwBoAAAAAwIBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAAD AwEGQGgAAAADAwEGQCgAAAADBAYAKAAAAAMECAAoAAAAAwIIAGgAAAADAQEI AGgAAAADAQEIAGgAAAADAQELAAEAAQIoAgIDIAMEKAIDBSAFBiAGB2gMBwho DAgJaAwJCmgMCgtoDAsMAAINIA0OKAIODyAPEGgMEBFoDBESaAwSE2gMExRo DBMVABUWCAIVFwgCFRgAGBkgGRpoDBobaAwbHGgMHB1oDB0eaAweHyAfICgC HyEgECIgASMgCwZoDBQPaAweGWgMQgMAAAAGBwgJCgsGBhAREhMUDwYaGxwd HhkXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:36:28Z</structure-indexed-at> </compound>